1.	Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000069098, NCCTG-N00C3, NCCTG-CCC-0020, NCI-P01-0196, NCT00027963
2.	Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000285700, GOG-0192, NCT00058071
3.	Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer Phase: Phase III Type: Supportive care Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000403155, MDA-CCC-0327, MDA-2004-0728, 2004-0728, NCT00112996
4.	Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Phase: Phase III Type: Supportive care Status: Completed Age: 3 to 20 Sponsor: NCI, Other Protocol IDs: SCUSF 0402, ACCL 0731, 5U10CA081920-11, HLMCC-0402, NCT00369564
5.	Topical Amitriptyline and Ketamine Cream in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000543103, U10CA037420, URCC-0605, URCC-07004, NCT00471445
6.	Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer Phase: Phase III Type: Supportive care Status: Closed Age: 25 and over Sponsor: NCI, Other Protocol IDs: CDR0000553389, CALGB-170601, NCT00489411
7.	Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000560732, NCCTG-N06CA, N06CA, NCT00516503
8.	S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, Stage II, or Stage IIIA Breast Cancer Undergoing Chemotherapy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000617081, S0715, U10CA037429, SWOG-S0715, NCT00775645
9.	Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000654097, NCCTG-N08CA, N08CA, NCT00979082
10.	Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer Phase: Phase III Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: RC08CC, NCI-2009-01229, 08-008811, CA163-195, NCT00998738
11.	Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000669660, NCCTG-N08CB, N08CB, NCT01099449
12.	Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Phase: Phase II Type: Supportive care, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000350089, U10CA031946, CALGB-30303, NCT00077311
13.	Electrical Stimulation Therapy Using the MC5-A Scrambler in Reducing Peripheral Neuropathy Caused by Chemotherapy Phase: Phase II Type: Supportive care Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000644516, MCV-MCC-12110, MCC-12110, NCT00952848
14.	MC5-A Scrambler Therapy in Reducing Peripheral Neuropathy Caused by Chemotherapy Phase: Phase II Type: Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: MC10C8, NCI-2011-00109, 10-007874, NCT01290224
15.	Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer Phase: No phase specified Type: Natural history/Epidemiology, Supportive care Status: Closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000433266, CALGB-70301, NCT00115505
16.	Nerve Changes in Patients Who Are Undergoing Chemotherapy or Biological Therapy for Cancer Phase: No phase specified Type: Supportive care Status: Completed Age: 21 to 85 Sponsor: NCI, Other Protocol IDs: CASE13Z04, P30CA043703, CASE-120411, NCT00281853